Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.

Background: Raloxifene and alendronate are anti-resorptive therapies approved for the prevention and treatment of postmenopausal osteoporosis. Raloxifene is also indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk...

Full description

Bibliographic Details

Published in:	BMC Women's Health Vol. 13; no. 1; pp. 15 - 16
Main Authors:	Foster, Shonda A, Shi, Nianwen, Curkendall, Suellen, Stock, John, Chu, Bong-Chul, Burge, Russel, Diakun, David R, Krege, John H
Format:	research Journal Article
Published:	BioMed Central 2013
Online Access:	View this record in EBSCOhost